Cleared Traditional

K232674 - PainFreeze II (FDA 510(k) Clearance)

Feb 2024
Decision
164d
Days
-
Risk

K232674 is an FDA 510(k) clearance for the PainFreeze II. This device is classified as a Vapocoolant Device.

Submitted by Nuance Medical, LLC (Carlsbad, US). The FDA issued a Cleared decision on February 12, 2024, 164 days after receiving the submission on September 1, 2023.

This device falls under the Physical Medicine FDA review panel.

Submission Details

510(k) Number K232674 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 01, 2023
Decision Date February 12, 2024
Days to Decision 164 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF

Device Classification

Product Code MLY - Vapocoolant Device
Device Class -